OPTI FORM

Brand Owner (click to sort) Address Description
OPTIFORM UNI LAC CORP. 50 Ash Circle Warminster PA 18947 OPTI FORM;porcelain and plastic teeth;
OPTIFORM CATALENT PHARMA SOLUTIONS, INC. 14 Schoolhouse Road Somerset NJ 08873 OPTI FORM;Scientific research services; Chemical compound and chemical compound library research and development services; Pharmaceutical research and development, namely, screening drug targets; Pharmaceutical research and development, namely, automated screening of pharmaceutical and chemical compounds; Pharmaceutical products development; Pharmaceutical drug development services; Scientific and technological services, namely, scientific research, analysis, screening and testing in the field of oral dose drug development; Conducting scientific feasibility studies; Pharmaceutical research services, namely, screening and identifying optimal active pharmaceutical ingredient (API) forms, optimized final dosing forms, dosing profiles, optimal formulation of pharmaceutical products, determination of drug substance state for enhanced bioavailability, ingredient compatibility screening, solid state screening and comparative analytical testing of drug substance states; Consulting services in the fields of pharmaceutical product development, optimization of optimal active pharmaceutical ingredient (API) design, formulation of pharmaceutical products and drug product design;
 

Where the owner name is not linked, that owner no longer owns the brand

   
Technical Examples
  1. A method of preparing cabergoline Form I, comprising forming a solvate including cabergoline and 4-fluorotoluene or 1,3,5-trimethylbenzene and obtaining cabergoline Form I from the solvate. Another aspect of the present invention provides a method for preparing cabergoline Form I comprising dissolving cabergoline in 4-fluorotoluene or 1,3,5-trimethylbenzene and recovering the cabergoline Form 1 polymorph. Cabergoline Form I can then be obtained from the solution, suitably by direct crystallization of Form I or by recovery of a solvate which can be converted to Form I.